• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型非整合性DNA纳米S/MAR载体在同基因患者来源的胰腺肿瘤模型中恢复基因功能。

Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models.

作者信息

Bozza Matthias, Green Edward W, Espinet Elisa, De Roia Alice, Klein Corinna, Vogel Vanessa, Offringa Rienk, Williams James A, Sprick Martin, Harbottle Richard P

机构信息

DNA Vector Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120 Heidelberg, Germany.

Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

出版信息

Mol Ther Methods Clin Dev. 2020 Apr 25;17:957-968. doi: 10.1016/j.omtm.2020.04.017. eCollection 2020 Jun 12.

DOI:10.1016/j.omtm.2020.04.017
PMID:32420409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7218229/
Abstract

We describe herein non-integrating minimally sized nano-S/MAR DNA vectors, which can be used to genetically modify dividing cells in place of integrating vectors. They represent a unique genetic tool, which avoids vector-mediated damage. Previous work has shown that DNA vectors comprising a mammalian S/MAR element can provide persistent mitotic stability over hundreds of cell divisions, resisting epigenetic silencing and thereby allowing sustained transgene expression. The composition of the original S/MAR vectors does present some inherent limitations that can provoke cellular toxicity. Herein, we present a new system, the nano-S/MAR, which drives higher transgene expression and has improved efficiency of establishment, minimal impact on cellular processes and perturbation of the endogenous transcriptome. We show that these features enable the hitherto challenging genetic modification of patient-derived cells to stably restore the tumor suppressor gene SMAD4 to a patient-derived knockout pancreatic cancer line. Nano-S/MAR modification does not alter the molecular or phenotypic integrity of the patient-derived cells in cell culture and xenograft mouse models. In conclusion, we show that these DNA vectors can be used to persistently modify a range of cells, providing sustained transgene expression while avoiding the risks of insertional mutagenesis and other vector-mediated toxicity.

摘要

我们在此描述了非整合型极小尺寸的纳米S/MAR DNA载体,其可用于对分裂细胞进行基因改造,以替代整合型载体。它们代表了一种独特的基因工具,可避免载体介导的损伤。先前的研究表明,包含哺乳动物S/MAR元件的DNA载体可在数百次细胞分裂中提供持久的有丝分裂稳定性,抵抗表观遗传沉默,从而实现持续的转基因表达。原始S/MAR载体的组成确实存在一些可能引发细胞毒性的固有局限性。在此,我们提出了一种新系统——纳米S/MAR,其可驱动更高的转基因表达,具有更高的建立效率,对细胞过程的影响最小,对内源转录组的干扰也最小。我们表明,这些特性使得对患者来源的细胞进行迄今为止具有挑战性的基因改造成为可能,从而将肿瘤抑制基因SMAD4稳定地恢复到患者来源的敲除型胰腺癌系中。在细胞培养和异种移植小鼠模型中,纳米S/MAR修饰不会改变患者来源细胞的分子或表型完整性。总之,我们表明这些DNA载体可用于对一系列细胞进行持久改造,在避免插入诱变风险和其他载体介导的毒性的同时提供持续的转基因表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/afb42674deb6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/9f288375201b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/73f61f14b8c8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/ccfd71641da7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/85ba9308e350/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/07685c6893d0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/afb42674deb6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/9f288375201b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/73f61f14b8c8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/ccfd71641da7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/85ba9308e350/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/07685c6893d0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d5/7218229/afb42674deb6/gr5.jpg

相似文献

1
Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models.新型非整合性DNA纳米S/MAR载体在同基因患者来源的胰腺肿瘤模型中恢复基因功能。
Mol Ther Methods Clin Dev. 2020 Apr 25;17:957-968. doi: 10.1016/j.omtm.2020.04.017. eCollection 2020 Jun 12.
2
Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells.基于最小S/MAR序列的非整合慢病毒载体在分裂细胞中保留转基因表达。
Sci China Life Sci. 2016 Oct;59(10):1024-1033. doi: 10.1007/s11427-016-0067-0. Epub 2016 Sep 6.
3
Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver.开发 S/MAR 微环以增强和持久表达小鼠肝脏中的转基因。
J Mol Med (Berl). 2011 May;89(5):515-29. doi: 10.1007/s00109-010-0713-3. Epub 2011 Feb 8.
4
Influence of insulators on transgene expression from integrating and non-integrating lentiviral vectors.绝缘子对整合型和非整合型慢病毒载体转基因表达的影响。
Genet Vaccines Ther. 2011 Jan 4;9(1):1. doi: 10.1186/1479-0556-9-1.
5
Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage.非病毒 S/MAR 载体在提供选择优势时会在体内以附加体形式复制。
Gene Ther. 2011 Jan;18(1):82-7. doi: 10.1038/gt.2010.116. Epub 2010 Aug 26.
6
Physiological levels of HBB transgene expression from S/MAR element-based replicating episomal vectors.基于S/MAR元件的复制型附加型载体中HBB转基因表达的生理水平。
J Biotechnol. 2009 Aug 20;143(2):85-94. doi: 10.1016/j.jbiotec.2009.06.018. Epub 2009 Jun 25.
7
Handling S/MAR vectors.处理S/MAR载体。
Cold Spring Harb Protoc. 2012 Jun 1;2012(6):657-63. doi: 10.1101/pdb.top068262.
8
Genetic modification of cancer cells using non-viral, episomal S/MAR vectors for in vivo tumour modelling.利用非病毒、染色体外 S/MAR 载体对癌细胞进行遗传修饰,用于体内肿瘤建模。
PLoS One. 2012;7(10):e47920. doi: 10.1371/journal.pone.0047920. Epub 2012 Oct 26.
9
The functional role of S/MARs in episomal vectors as defined by the stress-induced destabilization profile of the vector sequences.由载体序列的应激诱导去稳定化概况所定义的S/MARs在游离型载体中的功能作用。
J Mol Biol. 2009 Apr 17;387(5):1239-49. doi: 10.1016/j.jmb.2009.02.043. Epub 2009 Feb 25.
10
Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation.非病毒游离型载体上编码的转基因的表达不会因胞嘧啶甲基化而发生表观遗传沉默。
Mol Biol Rep. 2004 Jun;31(2):85-90. doi: 10.1023/b:mole.0000031363.35839.46.

引用本文的文献

1
Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells.源自S/MAR载体转染的人诱导多能干细胞的黑色素瘤抗原特异性CD8 + T细胞的生成及功能分析。
Int J Cancer. 2025 Nov 1;157(9):1876-1887. doi: 10.1002/ijc.35524. Epub 2025 Jun 12.
2
Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector.通过用游离DNA载体工程化的肾类器官进行促红细胞生成素递送。
Stem Cell Res Ther. 2025 Apr 12;16(1):174. doi: 10.1186/s13287-025-04282-w.
3
Viral and cellular insulators promote sustained HSV vector-mediated transgene expression in brain.

本文引用的文献

1
Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌中新型亚型特异性蛋白质生物标志物的鉴定与验证
Pancreas. 2017 Mar;46(3):311-322. doi: 10.1097/MPA.0000000000000743.
2
Pancreatic cancer: yesterday, today and tomorrow.胰腺癌:昨天、今天与明天。
Future Oncol. 2016 Aug;12(16):1929-46. doi: 10.2217/fon-2016-0010. Epub 2016 Jun 1.
3
TGF-β Tumor Suppression through a Lethal EMT.通过致死性上皮-间质转化实现的转化生长因子-β肿瘤抑制作用
病毒和细胞绝缘子促进单纯疱疹病毒载体介导的转基因在大脑中的持续表达。
Mol Ther. 2025 Apr 2;33(4):1420-1433. doi: 10.1016/j.ymthe.2025.02.039. Epub 2025 Feb 28.
4
Safe CAR-T: shedding light on CAR-related T-cell malignancies.安全的嵌合抗原受体T细胞疗法:揭示与嵌合抗原受体相关的T细胞恶性肿瘤
EMBO Mol Med. 2025 Apr;17(4):589-593. doi: 10.1038/s44321-025-00205-7. Epub 2025 Feb 28.
5
Current Non-Viral-Based Strategies to Manufacture CAR-T Cells.当前基于非病毒的嵌合抗原受体T细胞制造策略。
Int J Mol Sci. 2024 Dec 21;25(24):13685. doi: 10.3390/ijms252413685.
6
In Vivo Selection of S/MAR Sequences to Favour AAV Episomal Maintenance in Dividing Cells.在体内选择基质附着区域(S/MAR)序列以促进腺相关病毒(AAV)在分裂细胞中的游离型维持
Int J Mol Sci. 2024 Nov 27;25(23):12734. doi: 10.3390/ijms252312734.
7
A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors.使用 SMAR DNA 载体的一种简单的非病毒方法来生成人诱导多能干细胞。
Genes (Basel). 2024 Apr 30;15(5):575. doi: 10.3390/genes15050575.
8
Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors.使用下一代纳米质粒载体提高细胞和基因治疗的安全性及性能。
Mol Ther Nucleic Acids. 2023 Apr 7;32:494-503. doi: 10.1016/j.omtn.2023.04.003. eCollection 2023 Jun 13.
9
Successful large gene augmentation of USH2A with non-viral episomal vectors.成功地利用非病毒的附加型载体对 USH2A 进行了大型基因扩增。
Mol Ther. 2023 Sep 6;31(9):2755-2766. doi: 10.1016/j.ymthe.2023.06.012. Epub 2023 Jun 19.
10
Genetic manipulation and targeted protein degradation in mammalian systems: practical considerations, tips and tricks for discovery research.哺乳动物系统中的基因操作和靶向蛋白降解:发现研究的实用考虑、技巧和窍门。
FEBS Open Bio. 2023 Jul;13(7):1164-1176. doi: 10.1002/2211-5463.13581. Epub 2023 Mar 8.
Cell. 2016 Feb 25;164(5):1015-30. doi: 10.1016/j.cell.2016.01.009. Epub 2016 Feb 18.
4
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.细胞色素P450 3A5(CYP3A5)介导不同亚型胰腺导管腺癌的基础和获得性治疗耐药性。
Nat Med. 2016 Mar;22(3):278-87. doi: 10.1038/nm.4038. Epub 2016 Feb 8.
5
Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.通过诱导性恢复TGF-β信号传导深入了解胰腺癌中SMAD4的缺失
Mol Endocrinol. 2015 Oct;29(10):1440-53. doi: 10.1210/me.2015-1102. Epub 2015 Aug 18.
6
Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation.波形蛋白通过介导细胞骨架组织和粘着斑成熟,对上皮-间质转化癌细胞力学产生影响。
Oncotarget. 2015 Jun 30;6(18):15966-83. doi: 10.18632/oncotarget.3862.
7
European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?2015 年欧洲癌症死亡率预测:肺癌是否是欧盟女性中死亡率最高的癌症?
Ann Oncol. 2015 Apr;26(4):779-786. doi: 10.1093/annonc/mdv001. Epub 2015 Jan 26.
8
SMAD4 and its role in pancreatic cancer.SMAD4 及其在胰腺癌中的作用。
Tumour Biol. 2015 Jan;36(1):111-9. doi: 10.1007/s13277-014-2883-z. Epub 2014 Dec 3.
9
Pancreatic adenocarcinoma.胰腺腺癌
N Engl J Med. 2014 Nov 27;371(22):2140-1. doi: 10.1056/NEJMc1412266.
10
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.预计 2030 年美国癌症发病与死亡人数:甲状腺癌、肝癌和胰腺癌带来的意外负担。
Cancer Res. 2014 Jun 1;74(11):2913-21. doi: 10.1158/0008-5472.CAN-14-0155.